financetom
Business
financetom
/
Business
/
Thermax says order intake up 28% YoY in Q2, weak IIP a temporary issue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Thermax says order intake up 28% YoY in Q2, weak IIP a temporary issue
Nov 14, 2019 5:53 AM

Thermax's second-quarter earnings were ahead of street estimates but profit after tax was hit by Rs 70 crore write-down of deferred assets. Managing director MS Unnikrishnan said Q2 results were positive as far as inputs in the company are concerned as Thermax's order intake for the quarter is 28 percent more than last year same quarter. “If I were to compare that with revenue recognition for the quarter, there is still an improvement into the order book at the end of September," he said.

Talking about weak IIP, Unnikrishnan said, “There is one single order which we have received of flue gas desulfurization system from one of the power plant of Rs 475 crore. This has helped me to ensure that there is an improvement but like the way capital goods IIP indicating in terms of minus 20 percent in the last month, I don’t think it is going to be a generic thing for Indian capital goods industry; it’s a temporary number.”

“However, going forward, further fresh orders to be taken in. There will be challenges but it is not such a bad story that people are projecting it to be; the sentiments are bad so the order conclusions may get delayed but otherwise things will start picking up a little later,” Unnikrishnan added.

On guidance front, he said, “I would not want to change the guidance because the larger orders which we received in the current quarter, the revenues will be recognized next year. So it’s giving me comfort for the forthcoming year than an improvement in the guidance to be given for the second half of the current year.”

Speaking about payments, the MD said, “There is a challenge in collecting payments. One has to overwork, but we have been very particular about that.”

“We do not overspend on a project unless cash flow is also matching with the efforts put in by us, but the retention money which is there with the PSUs by the way they put the tender, for example, any PSU tender will have a minimum 10 percentage of retention. So any equipment that is supplied in a 2 year project, 10 percent will remain retained by them by full 2 year period of time whereas I will be paying to my SME suppliers within 45 days. So those retentions are the ones which normally impacts the cash flow of companies,” he further added.

“Thermax being a zero debt organization, as of now also we have not borrowed any money to run the operations for working capital. We are managing with our own treasury,” Unnikrishnan added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Summit Therapeutics' Closely-Watched Lung Cancer Study Of Ivonescimab Misses Overall Survival Endpoint
Summit Therapeutics' Closely-Watched Lung Cancer Study Of Ivonescimab Misses Overall Survival Endpoint
May 30, 2025
Summit Therapeutics Inc. ( SMMT ) released topline results on Friday from the Phase 3 HARMONi trial of ivonescimab plus platinum-doublet chemotherapy compared to placebo plus platinum-doublet chemotherapy for epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) who have progressed after treatment with a 3rd generation EGFR tyrosine kinase inhibitor (TKI). The trial met the...
Herc Completes Tender Offer for H&E, Deal Close Set for June 2
Herc Completes Tender Offer for H&E, Deal Close Set for June 2
May 30, 2025
09:01 AM EDT, 05/30/2025 (MT Newswires) -- Herc Holdings ( HRI ) said Friday its tender offer to acquire H&E Equipment Services ( HEES ) expired at one minute past 11:59 pm ET on Thursday. The company said that roughly 69% of H&E shares were tendered by the deadline and will be paid in cash and stock as previously outlined....
Vivakor to Issue Special Dividend in Adapti Shares
Vivakor to Issue Special Dividend in Adapti Shares
May 30, 2025
09:05 AM EDT, 05/30/2025 (MT Newswires) -- Vivakor ( VIVK ) said Friday it plans to issue a special dividend of 0.0079 shares of Adapti per Vivakor ( VIVK ) share. Vivakor ( VIVK ), which currently holds at 13.5% stake in Adapti, said it will establish a record date for the dividend in the next couple of weeks. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved